Information Provided By:
Fly News Breaks for May 20, 2019
BMY
May 20, 2019 | 07:22 EDT
Argus analyst David Toung downgraded Bristol-Myers to Hold from Buy.
News For BMY From the Last 2 Days
BMY
Jun 24, 2019 | 16:24 EDT
The S&P 500 spent the day searching for direction near 2,950, just below last week’s record level as several sectors saw gains. Sitting out, however,... To see the rest of the story go to thefly.com. See Story Here
BMY
Jun 24, 2019 | 12:15 EDT
Stocks are mildly higher in trading so far, holding near all-time highs. Amid the broad... To see the rest of the story go to thefly.com. See Story Here
BMY
Jun 24, 2019 | 09:47 EDT
Bristol-Myers is down -5.1%, or -$2.52 to $46.82.
BMY
Jun 24, 2019 | 09:21 EDT
HIGHER: PCM, Inc. (PCMI), up 41% after entering into an agreement under which Insight Enterprises (NSIT) will acquire PCM for $35 per share... NRC Group (NRCG), up 26% after U.S. Ecology (ECOL) entered into a definitive merger agreement with the company in an all-stock transaction with an enterprise value of $966M... Caesars (CZR), up 14% after announcing that Eldorado Resorts (ERI) will acquire all of the outstanding shares of Caesars for a total value of $12.75 per share in cash and stock... Minerva (NERV), up 74% after seltorexant trial achieves primary, secondary endpoints... Trevana (TRVN), up 3% after the publication of APOLLO-2 results in Pain Practice on the effects of oliceridine for management of moderate-to-severe acute pain following abdominoplasty. LOWER: Eldorado Resorts (ERI), down 9% after acquiring all of the outstanding shares of Caesars... Bristol-Meyers (BMY) and Celgene (CELG), both down 3% after announcing, to allow the Celgene merger to close on a timely basis in light of concerns expressed by the FTC, Bristol-Meyers is planning the divestiture of Otezla... Spotify (SPOT), down 3% after being downgraded to Underperform from In Line at Evercore ISI.